SORRENTO THERAPEUTICS

YTD

ALL

Why Robinhood?

You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.

CEO

Henry H. Ji, PhD

CEOHenry H. Ji, PhD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

—

Employees—

SRNE Key Statistics

Market cap

771.80K

Market cap771.80K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

180.18K

Average volume180.18K

High today

$0.0014

High today$0.0014

Low today

$0.0014

Low today$0.0014

Open price

$0.0014

Open price$0.0014

Volume

1.59K

Volume1.59K

52 Week high

$0.021

52 Week high$0.021

52 Week low

$0.0001

52 Week low$0.0001

People also own

Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.

SORRENTO THERAPEUTICS

Why Robinhood?

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. Show more

SRNE Key Statistics

People also own

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.